Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cyprus Business Journal.
Press releases published on August 7, 2025
Rapid7 Announces Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
Annualized recurring revenue (“ARR”) of $841 million, an increase of 3% year-over-year Total revenue of $214 million, up 3% year-over-year; Product subscriptions revenue of $208 million, up 4% year-over-year GAAP operating income of $3.5 million; Non-GAAP …
Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
Early Human Pharmacokinetics Data for DT-216P2 Demonstrates Favorable Translation from Non-Human Primates (NHPs) to Humans and Improved DT-216 Product Profile for Friedreich Ataxia (FA) Program RESTORE-FA Phase 1/2 Multiple-Ascending Dose Trial of DT-216P2 …
Ascendis Pharma Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
– Q2 2025 revenue of €103.0 million for YORVIPATH® and €50.7 million for SKYTROFA® – TransCon® CNP (navepegritide) NDA under Priority Review for the treatment of children with achondroplasia with PDUFA date of November 30, 2025 – SKYTROFA® ( …
Tectonic Therapeutic Announces Second Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
August 7, 2025
TX45 PH-ILD Phase 2 clinical trial is planned to initiate in 2026 to evaluate TX45’s safety and hemodynamic effects in subjects with Pulmonary Hypertension associated with Interstitial Lung Disease (“PH-ILD”, Group 3 PH) to expand the therapeutic breadth …
Teknova Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
Second quarter 2025 total revenue was $10.3 million, up 7% from prior year Achieves four consecutive quarters of year-over-year revenue growth Company reaffirms 2025 revenue guidance of $39-42 million HOLLISTER, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- …
Research Frontiers Reports Second Quarter 2025 Financial Results and Will Host a Conference Call at 4:30p.m. Today
GlobeNewswire
·
August 7, 2025
WOODBURY, N.Y., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its second quarter of 2025. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its financial and …
RDDT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Reddit, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
August 7, 2025
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
August 7, 2025
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
REPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Replimune Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
August 7, 2025
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
LAZR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Luminar Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
August 7, 2025
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
FI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fiserv, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
August 7, 2025
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
CAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
August 7, 2025
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising-- Bronstein, Gewirtz …
VSTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Vestis Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
August 7, 2025
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising-- Bronstein, Gewirtz …
PEPG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that PepGen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
August 7, 2025
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
August 7, 2025
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz …
aTyr Pharma Announces Second Quarter 2025 Results and Provides Corporate Update
GlobeNewswire
·
August 7, 2025
SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase …
IN8bio Reports Second Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
August 7, 2025
Delivered an oral presentation at ASCO 2025 Annual Meeting, demonstrating extended median progression-free survival (mPFS) in patients receiving multiple doses of INB-200, including a patient remaining progression-free for over four years. Received the …
Nephros Announces Strong Second Quarter Financial Results
GlobeNewswire
·
August 7, 2025
SOUTH ORANGE, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the second quarter ended June …
PDF Solutions® Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
SANTA CLARA, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- PDF Solutions, Inc. (Nasdaq: PDFS), a leading provider of comprehensive data solutions for the semiconductor and electronics ecosystem, today announced financial results for its second quarter ended …
Cytokinetics Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 7, 2025
Regulatory Reviews of Aficamten for Obstructive HCM Progressing in U.S., E.U. and China; Late-Cycle Meeting with U.S. FDA Scheduled for September Ahead of December 26, 2025 PDUFA Date Primary Results from MAPLE-HCM to be Presented in a Hot Line Session at …